A potential acetyltransferase involved in Leishmania major metacaspase-dependent cell death

BACKGROUND: Currently, there is no satisfactory treatment for leishmaniases, owing to the cost, mode of administration, side effects and to the increasing emergence of drug resistance. As a consequence, the proteins involved in Leishmania apoptosis seem a target of choice for the development of new...

Descripción completa

Detalles Bibliográficos
Autores principales: Basmaciyan, Louise, Azas, Nadine, Casanova, Magali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537415/
https://www.ncbi.nlm.nih.gov/pubmed/31133064
http://dx.doi.org/10.1186/s13071-019-3526-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537415/
https://www.ncbi.nlm.nih.gov/pubmed/31133064
http://dx.doi.org/10.1186/s13071-019-3526-4

Ejemplares similares